Trial Outcomes & Findings for Repetitive Transcranial Magnetic Stimulation for Treating Depression: A Functional Magnetic Resonance Imaging Study (NCT NCT01162382)

NCT ID: NCT01162382

Last Updated: 2019-02-18

Results Overview

HDRS-24 will be used to measure response to rTMS treatment. A 50% decrease in HDRS-24 score will indicate treatment response; HDRS-24 \< 10 will indicate remission.

Recruitment status

TERMINATED

Study phase

NA

Target enrollment

4 participants

Primary outcome timeframe

At study entry and within 2 days of exiting 4 weeks of rTMS treatment

Results posted on

2019-02-18

Participant Flow

Participant milestones

Participant milestones
Measure
Transcranial Magnetic Stimulation
Open-label transcranial magnetic stimulation Transcranial Magnetic Stimulation: Four 100-second trains and then one 65-second train, with 30-second inter-train intervals, at 1 Hz and 120% of the resting motor threshold will be applied over the right dorsolateral prefrontal cortex. Subsequently, twenty-five 30-second trains, with a 30-second inter-train interval, at 10 Hz and 120% of the resting motor threshold will be applied over the left dorsolateral prefrontal cortex.
Overall Study
STARTED
0
Overall Study
COMPLETED
0
Overall Study
NOT COMPLETED
0

Reasons for withdrawal

Withdrawal data not reported

Baseline Characteristics

Repetitive Transcranial Magnetic Stimulation for Treating Depression: A Functional Magnetic Resonance Imaging Study

Baseline characteristics by cohort

Baseline data not reported

PRIMARY outcome

Timeframe: At study entry and within 2 days of exiting 4 weeks of rTMS treatment

Population: No data are available for this study as the study was terminated and PI has left the institution. Multiple efforts to contact the PI for the relevant data have failed.

HDRS-24 will be used to measure response to rTMS treatment. A 50% decrease in HDRS-24 score will indicate treatment response; HDRS-24 \< 10 will indicate remission.

Outcome measures

Outcome data not reported

SECONDARY outcome

Timeframe: At study entry and within 2 days of exiting 4 weeks of rTMS treatment

Population: No data are available for this study as the study was terminated and PI has left the institution. Multiple efforts to contact the PI for the relevant data have failed.

Imaging studies will be compared to determine if any changes in functional connectivity can be correlated with treatment response.

Outcome measures

Outcome data not reported

Adverse Events

Transcranial Magnetic Stimulation

Serious events: 0 serious events
Other events: 0 other events
Deaths: 0 deaths

Serious adverse events

Adverse event data not reported

Other adverse events

Adverse event data not reported

Additional Information

Kathy Pierce

Washington University School of Medicine

Phone: 314-362-5626

Results disclosure agreements

  • Principal investigator is a sponsor employee
  • Publication restrictions are in place